search results for 


We will continue to invest in our future growth. In 2013, we expect to invest about 5% of sales in property, plant and equipment, which will be roughly in line with the 2012 rate.

About 50% of the capital expenditure planned will be invested at Fresenius Medical Care, about 30% at Fresenius Kabi, and about 20% at Fresenius Helios. Investments at Fresenius Medical Care will focus primarily on the ongoing modernization of dialysis clinics and production facilities, on the opening of new dialysis clinics, and the expansion of its worldwide production capacities.

Fresenius Kabi will primarily invest in expanding and maintaining production facilities as well as in introducing new manufacturing technologies, enabling further improvements in production efficiency. At Fresenius Helios, we will primarily be investing in modernizing and equipping hospitals.

The regional focus of the Group’s investment spending will be on Europe and North America, which will account for about 60% and 25%, respectively. The remainder will be invested in Asia, Latin America, and Africa. About 35% of total funds will be invested in Germany.

Back to:
Continue reading: